nodes	percent_of_prediction	percent_of_DWPC	metapath
Rasagiline—CYP1A2—Carmustine—brain cancer	0.209	0.771	CbGbCtD
Rasagiline—CYP1A2—Etoposide—brain cancer	0.0621	0.229	CbGbCtD
Rasagiline—BCL2—TP53 Network—OTX2—brain cancer	0.0246	0.134	CbGpPWpGaD
Rasagiline—CYP1A2—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP2C9—brain cancer	0.006	0.0326	CbGpPWpGaD
Rasagiline—CYP1A2—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP2C9—brain cancer	0.00546	0.0296	CbGpPWpGaD
Rasagiline—MAOB—ganglion—brain cancer	0.00465	0.113	CbGeAlD
Rasagiline—BCL2—Direct p53 effectors—HIC1—brain cancer	0.00444	0.0241	CbGpPWpGaD
Rasagiline—BCL2—telencephalon—brain cancer	0.00431	0.105	CbGeAlD
Rasagiline—BCL2—IL2 signaling events mediated by STAT5—CDK6—brain cancer	0.00427	0.0232	CbGpPWpGaD
Rasagiline—MAOB—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.00419	0.0228	CbGpPWpGaD
Rasagiline—BCL2—gonad—brain cancer	0.0036	0.0877	CbGeAlD
Rasagiline—MAOB—hindbrain—brain cancer	0.00353	0.086	CbGeAlD
Rasagiline—CYP1A2—Xenobiotics—CYP2C9—brain cancer	0.00288	0.0157	CbGpPWpGaD
Rasagiline—CYP1A2—Tamoxifen metabolism—CYP2C9—brain cancer	0.00277	0.0151	CbGpPWpGaD
Rasagiline—BCL2—endocrine gland—brain cancer	0.00272	0.0663	CbGeAlD
Rasagiline—BCL2—TP53 Network—CDKN2A—brain cancer	0.00271	0.0147	CbGpPWpGaD
Rasagiline—BCL2—head—brain cancer	0.00268	0.0655	CbGeAlD
Rasagiline—BCL2—Inflammasomes—RELA—brain cancer	0.0025	0.0136	CbGpPWpGaD
Rasagiline—BCL2—EPO signaling pathway—IRS2—brain cancer	0.00249	0.0135	CbGpPWpGaD
Rasagiline—BCL2—IL-3 Signaling Pathway—VAV1—brain cancer	0.00247	0.0134	CbGpPWpGaD
Rasagiline—BCL2—central nervous system—brain cancer	0.00245	0.0597	CbGeAlD
Rasagiline—BCL2—Focal Adhesion—PPP1R12A—brain cancer	0.00241	0.0131	CbGpPWpGaD
Rasagiline—BCL2—Signaling events mediated by Stem cell factor receptor (c-Kit)—VAV1—brain cancer	0.00239	0.013	CbGpPWpGaD
Rasagiline—BCL2—Direct p53 effectors—PMS2—brain cancer	0.00233	0.0127	CbGpPWpGaD
Rasagiline—MAOB—Biological oxidations—CYP2C9—brain cancer	0.00223	0.0121	CbGpPWpGaD
Rasagiline—BCL2—Kit receptor signaling pathway—VAV1—brain cancer	0.00212	0.0115	CbGpPWpGaD
Rasagiline—MAOB—brainstem—brain cancer	0.00202	0.0493	CbGeAlD
Rasagiline—BCL2—brain—brain cancer	0.00194	0.0474	CbGeAlD
Rasagiline—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2C9—brain cancer	0.00188	0.0102	CbGpPWpGaD
Rasagiline—BCL2—C-MYB transcription factor network—CDK6—brain cancer	0.00187	0.0102	CbGpPWpGaD
Rasagiline—BCL2—IL-5 Signaling Pathway—PIK3CG—brain cancer	0.00184	0.01	CbGpPWpGaD
Rasagiline—BCL2—TP53 Network—MYC—brain cancer	0.00184	0.00999	CbGpPWpGaD
Rasagiline—BCL2—ATF-2 transcription factor network—HES1—brain cancer	0.00183	0.00993	CbGpPWpGaD
Rasagiline—BCL2—Apoptosis—DAPK1—brain cancer	0.00183	0.00993	CbGpPWpGaD
Rasagiline—BCL2—Integrated Cancer Pathway—CDK4—brain cancer	0.00181	0.00985	CbGpPWpGaD
Rasagiline—MAOB—telencephalon—brain cancer	0.00179	0.0438	CbGeAlD
Rasagiline—BCL2—ATF-2 transcription factor network—PDGFRA—brain cancer	0.00174	0.00945	CbGpPWpGaD
Rasagiline—BCL2—HIV-1 Nef: Negative effector of Fas and TNF-alpha—RELA—brain cancer	0.00168	0.00912	CbGpPWpGaD
Rasagiline—BCL2—IL2-mediated signaling events—IRS2—brain cancer	0.00164	0.00891	CbGpPWpGaD
Rasagiline—BCL2—IL2 signaling events mediated by STAT5—IL2—brain cancer	0.00163	0.00886	CbGpPWpGaD
Rasagiline—BCL2—IL2 signaling events mediated by PI3K—RELA—brain cancer	0.00153	0.00832	CbGpPWpGaD
Rasagiline—BCL2—TP53 Network—TP53—brain cancer	0.00151	0.0082	CbGpPWpGaD
Rasagiline—MAOB—pituitary gland—brain cancer	0.00146	0.0356	CbGeAlD
Rasagiline—BCL2—ATF-2 transcription factor network—CDK4—brain cancer	0.00143	0.00779	CbGpPWpGaD
Rasagiline—MAOB—medulla oblongata—brain cancer	0.00141	0.0344	CbGeAlD
Rasagiline—CYP1A2—Arachidonic acid metabolism—CYP2C9—brain cancer	0.00138	0.00752	CbGpPWpGaD
Rasagiline—BCL2—IL2 signaling events mediated by PI3K—IL2—brain cancer	0.00138	0.00749	CbGpPWpGaD
Rasagiline—BCL2—C-MYB transcription factor network—HES1—brain cancer	0.00138	0.00749	CbGpPWpGaD
Rasagiline—BCL2—Interleukin-11 Signaling Pathway—RELA—brain cancer	0.00133	0.00724	CbGpPWpGaD
Rasagiline—BCL2—IL-5 Signaling Pathway—IL2—brain cancer	0.0013	0.00704	CbGpPWpGaD
Rasagiline—MAOB—midbrain—brain cancer	0.00129	0.0314	CbGeAlD
Rasagiline—BCL2—IL2 signaling events mediated by STAT5—MYC—brain cancer	0.00128	0.00693	CbGpPWpGaD
Rasagiline—MAOB—spinal cord—brain cancer	0.00126	0.0307	CbGeAlD
Rasagiline—BCL2—IL-2 Signaling Pathway—IL2—brain cancer	0.00125	0.00677	CbGpPWpGaD
Rasagiline—BCL2—Ceramide signaling pathway—RELA—brain cancer	0.00124	0.00676	CbGpPWpGaD
Rasagiline—BCL2—Activation of BH3-only proteins—TP53—brain cancer	0.00121	0.00658	CbGpPWpGaD
Rasagiline—BCL2—Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways—RELA—brain cancer	0.0012	0.00654	CbGpPWpGaD
Rasagiline—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.0012	0.0065	CbGpPWpGaD
Rasagiline—CYP1A2—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.00118	0.00641	CbGpPWpGaD
Rasagiline—BCL2—Integrated Pancreatic Cancer Pathway—SHH—brain cancer	0.00115	0.00624	CbGpPWpGaD
Rasagiline—MAOB—endocrine gland—brain cancer	0.00113	0.0276	CbGeAlD
Rasagiline—MAOB—head—brain cancer	0.00112	0.0273	CbGeAlD
Rasagiline—BCL2—DNA Damage Response (only ATM dependent)—SOD2—brain cancer	0.00112	0.00607	CbGpPWpGaD
Rasagiline—BCL2—IL-5 Signaling Pathway—STAT3—brain cancer	0.00109	0.00592	CbGpPWpGaD
Rasagiline—BCL2—Integrated Pancreatic Cancer Pathway—SMO—brain cancer	0.00109	0.00592	CbGpPWpGaD
Rasagiline—BCL2—IL2 signaling events mediated by PI3K—MYC—brain cancer	0.00108	0.00586	CbGpPWpGaD
Rasagiline—BCL2—IL-2 Signaling Pathway—STAT3—brain cancer	0.00105	0.0057	CbGpPWpGaD
Rasagiline—BCL2—Senescence and Autophagy in Cancer—PCNA—brain cancer	0.00105	0.00568	CbGpPWpGaD
Rasagiline—MAOB—central nervous system—brain cancer	0.00102	0.0249	CbGeAlD
Rasagiline—BCL2—IL2-mediated signaling events—IL2—brain cancer	0.00102	0.00554	CbGpPWpGaD
Rasagiline—BCL2—IL-5 Signaling Pathway—MYC—brain cancer	0.00101	0.00551	CbGpPWpGaD
Rasagiline—BCL2—Interleukin-11 Signaling Pathway—STAT3—brain cancer	0.00101	0.00549	CbGpPWpGaD
Rasagiline—MAOB—cerebellum—brain cancer	0.000997	0.0243	CbGeAlD
Rasagiline—BCL2—Validated targets of C-MYC transcriptional repression—ERBB2—brain cancer	0.000994	0.0054	CbGpPWpGaD
Rasagiline—BCL2—IL-2 Signaling Pathway—MYC—brain cancer	0.000974	0.00529	CbGpPWpGaD
Rasagiline—CYP1A2—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.00097	0.00527	CbGpPWpGaD
Rasagiline—Cough—Procarbazine—brain cancer	0.000945	0.00188	CcSEcCtD
Rasagiline—Dysphagia—Temozolomide—brain cancer	0.000939	0.00187	CcSEcCtD
Rasagiline—BCL2—Integrated Cancer Pathway—MYC—brain cancer	0.000939	0.0051	CbGpPWpGaD
Rasagiline—Convulsion—Procarbazine—brain cancer	0.000938	0.00186	CcSEcCtD
Rasagiline—Hypertension—Procarbazine—brain cancer	0.000935	0.00186	CcSEcCtD
Rasagiline—BCL2—IL-3 Signaling Pathway—STAT3—brain cancer	0.000927	0.00504	CbGpPWpGaD
Rasagiline—BCL2—ATF-2 transcription factor network—CCND1—brain cancer	0.000926	0.00503	CbGpPWpGaD
Rasagiline—Arthralgia—Procarbazine—brain cancer	0.000922	0.00183	CcSEcCtD
Rasagiline—BCL2—Integrated Pancreatic Cancer Pathway—ESR2—brain cancer	0.00092	0.005	CbGpPWpGaD
Rasagiline—Anxiety—Procarbazine—brain cancer	0.000918	0.00182	CcSEcCtD
Rasagiline—BCL2—Integrated Breast Cancer Pathway—BRCA2—brain cancer	0.000911	0.00495	CbGpPWpGaD
Rasagiline—Dry mouth—Procarbazine—brain cancer	0.000901	0.00179	CcSEcCtD
Rasagiline—BCL2—Signaling events mediated by Stem cell factor receptor (c-Kit)—STAT3—brain cancer	0.000898	0.00488	CbGpPWpGaD
Rasagiline—BCL2—Integrated Breast Cancer Pathway—SIRT1—brain cancer	0.000894	0.00486	CbGpPWpGaD
Rasagiline—Cardiac failure—Etoposide—brain cancer	0.000891	0.00177	CcSEcCtD
Rasagiline—Confusional state—Procarbazine—brain cancer	0.000891	0.00177	CcSEcCtD
Rasagiline—Vomiting—Lomustine—brain cancer	0.000885	0.00176	CcSEcCtD
Rasagiline—Dysuria—Temozolomide—brain cancer	0.000878	0.00174	CcSEcCtD
Rasagiline—BCL2—Validated targets of C-MYC transcriptional repression—CCND1—brain cancer	0.000878	0.00477	CbGpPWpGaD
Rasagiline—Infection—Procarbazine—brain cancer	0.000878	0.00174	CcSEcCtD
Rasagiline—BCL2—Ceramide signaling pathway—MYC—brain cancer	0.000876	0.00476	CbGpPWpGaD
Rasagiline—Angiopathy—Hydroxyurea—brain cancer	0.000873	0.00173	CcSEcCtD
Rasagiline—Upper respiratory tract infection—Temozolomide—brain cancer	0.000873	0.00173	CcSEcCtD
Rasagiline—Shock—Procarbazine—brain cancer	0.000869	0.00173	CcSEcCtD
Rasagiline—Pollakiuria—Temozolomide—brain cancer	0.000868	0.00172	CcSEcCtD
Rasagiline—BCL2—Intrinsic Pathway for Apoptosis—TP53—brain cancer	0.000867	0.00471	CbGpPWpGaD
Rasagiline—BCL2—Amyotrophic lateral sclerosis (ALS)—TP53—brain cancer	0.000867	0.00471	CbGpPWpGaD
Rasagiline—Erectile dysfunction—Temozolomide—brain cancer	0.000865	0.00172	CcSEcCtD
Rasagiline—Depression—Carmustine—brain cancer	0.000864	0.00172	CcSEcCtD
Rasagiline—Chills—Hydroxyurea—brain cancer	0.000863	0.00171	CcSEcCtD
Rasagiline—BCL2—IL2-mediated signaling events—STAT3—brain cancer	0.000858	0.00466	CbGpPWpGaD
Rasagiline—Photosensitivity reaction—Temozolomide—brain cancer	0.000857	0.0017	CcSEcCtD
Rasagiline—Hyperhidrosis—Procarbazine—brain cancer	0.000854	0.0017	CcSEcCtD
Rasagiline—Alopecia—Hydroxyurea—brain cancer	0.00085	0.00169	CcSEcCtD
Rasagiline—Weight decreased—Temozolomide—brain cancer	0.00085	0.00169	CcSEcCtD
Rasagiline—Neuropathy peripheral—Carmustine—brain cancer	0.000849	0.00169	CcSEcCtD
Rasagiline—BCL2—Direct p53 effectors—SPP1—brain cancer	0.000846	0.0046	CbGpPWpGaD
Rasagiline—Stomatitis—Carmustine—brain cancer	0.000845	0.00168	CcSEcCtD
Rasagiline—Anorexia—Procarbazine—brain cancer	0.000842	0.00167	CcSEcCtD
Rasagiline—Infestation—Temozolomide—brain cancer	0.000837	0.00166	CcSEcCtD
Rasagiline—Infestation NOS—Temozolomide—brain cancer	0.000837	0.00166	CcSEcCtD
Rasagiline—Depression—Temozolomide—brain cancer	0.000835	0.00166	CcSEcCtD
Rasagiline—BCL2—Focal Adhesion—VAV1—brain cancer	0.000834	0.00453	CbGpPWpGaD
Rasagiline—BCL2—Direct p53 effectors—PCNA—brain cancer	0.000831	0.00451	CbGpPWpGaD
Rasagiline—Nausea—Lomustine—brain cancer	0.000827	0.00164	CcSEcCtD
Rasagiline—BCL2—C-MYB transcription factor network—CDKN2A—brain cancer	0.000826	0.00449	CbGpPWpGaD
Rasagiline—BCL2—Apoptosis—CDKN2A—brain cancer	0.000826	0.00449	CbGpPWpGaD
Rasagiline—BCL2—DNA Damage Response (only ATM dependent)—APC—brain cancer	0.000826	0.00449	CbGpPWpGaD
Rasagiline—BCL2—DNA Damage Response (only ATM dependent)—PIK3CG—brain cancer	0.000826	0.00449	CbGpPWpGaD
Rasagiline—Hypotension—Procarbazine—brain cancer	0.000826	0.00164	CcSEcCtD
Rasagiline—Neuropathy peripheral—Temozolomide—brain cancer	0.000821	0.00163	CcSEcCtD
Rasagiline—Stomatitis—Temozolomide—brain cancer	0.000816	0.00162	CcSEcCtD
Rasagiline—MAOB—brain—brain cancer	0.00081	0.0197	CbGeAlD
Rasagiline—CYP1A2—endocrine gland—brain cancer	0.000806	0.0197	CbGeAlD
Rasagiline—Musculoskeletal discomfort—Procarbazine—brain cancer	0.000805	0.0016	CcSEcCtD
Rasagiline—Insomnia—Procarbazine—brain cancer	0.000799	0.00159	CcSEcCtD
Rasagiline—BCL2—Kit receptor signaling pathway—STAT3—brain cancer	0.000799	0.00434	CbGpPWpGaD
Rasagiline—BCL2—IL2-mediated signaling events—MYC—brain cancer	0.000797	0.00433	CbGpPWpGaD
Rasagiline—BCL2—Apoptosis—RELA—brain cancer	0.000795	0.00432	CbGpPWpGaD
Rasagiline—Paraesthesia—Procarbazine—brain cancer	0.000793	0.00158	CcSEcCtD
Rasagiline—Somnolence—Procarbazine—brain cancer	0.000785	0.00156	CcSEcCtD
Rasagiline—Haemoglobin—Carmustine—brain cancer	0.000782	0.00155	CcSEcCtD
Rasagiline—Haemorrhage—Carmustine—brain cancer	0.000778	0.00154	CcSEcCtD
Rasagiline—Ill-defined disorder—Hydroxyurea—brain cancer	0.000777	0.00154	CcSEcCtD
Rasagiline—BCL2—Apoptosis Modulation and Signaling—CDKN2A—brain cancer	0.000775	0.00421	CbGpPWpGaD
Rasagiline—Anaemia—Hydroxyurea—brain cancer	0.000774	0.00154	CcSEcCtD
Rasagiline—Hallucination—Carmustine—brain cancer	0.000774	0.00154	CcSEcCtD
Rasagiline—Hypoaesthesia—Carmustine—brain cancer	0.000774	0.00154	CcSEcCtD
Rasagiline—BCL2—Integrated Cancer Pathway—TP53—brain cancer	0.000771	0.00419	CbGpPWpGaD
Rasagiline—Decreased appetite—Procarbazine—brain cancer	0.000768	0.00153	CcSEcCtD
Rasagiline—Oedema peripheral—Carmustine—brain cancer	0.000766	0.00152	CcSEcCtD
Rasagiline—Connective tissue disorder—Carmustine—brain cancer	0.000764	0.00152	CcSEcCtD
Rasagiline—Haemoglobin—Temozolomide—brain cancer	0.000756	0.0015	CcSEcCtD
Rasagiline—Malaise—Hydroxyurea—brain cancer	0.000755	0.0015	CcSEcCtD
Rasagiline—Constipation—Procarbazine—brain cancer	0.000755	0.0015	CcSEcCtD
Rasagiline—BCL2—Integrated Pancreatic Cancer Pathway—BRCA2—brain cancer	0.000755	0.0041	CbGpPWpGaD
Rasagiline—Haemorrhage—Temozolomide—brain cancer	0.000752	0.00149	CcSEcCtD
Rasagiline—Dysphagia—Etoposide—brain cancer	0.000752	0.00149	CcSEcCtD
Rasagiline—Leukopenia—Hydroxyurea—brain cancer	0.00075	0.00149	CcSEcCtD
Rasagiline—Hallucination—Temozolomide—brain cancer	0.000748	0.00149	CcSEcCtD
Rasagiline—Hypoaesthesia—Temozolomide—brain cancer	0.000748	0.00149	CcSEcCtD
Rasagiline—Urinary tract disorder—Temozolomide—brain cancer	0.000742	0.00147	CcSEcCtD
Rasagiline—Oedema peripheral—Temozolomide—brain cancer	0.000741	0.00147	CcSEcCtD
Rasagiline—BCL2—Integrated Pancreatic Cancer Pathway—SIRT1—brain cancer	0.000741	0.00402	CbGpPWpGaD
Rasagiline—BCL2—Corticotropin-releasing hormone—RELA—brain cancer	0.000739	0.00401	CbGpPWpGaD
Rasagiline—Connective tissue disorder—Temozolomide—brain cancer	0.000739	0.00147	CcSEcCtD
Rasagiline—Urethral disorder—Temozolomide—brain cancer	0.000737	0.00146	CcSEcCtD
Rasagiline—BCL2—Integrated Pancreatic Cancer Pathway—CCNE1—brain cancer	0.000731	0.00397	CbGpPWpGaD
Rasagiline—Feeling abnormal—Procarbazine—brain cancer	0.000728	0.00145	CcSEcCtD
Rasagiline—Eye disorder—Carmustine—brain cancer	0.000727	0.00144	CcSEcCtD
Rasagiline—Convulsion—Hydroxyurea—brain cancer	0.000726	0.00144	CcSEcCtD
Rasagiline—Gastrointestinal pain—Procarbazine—brain cancer	0.000722	0.00143	CcSEcCtD
Rasagiline—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—brain cancer	0.000708	0.00141	CcSEcCtD
Rasagiline—Discomfort—Hydroxyurea—brain cancer	0.000705	0.0014	CcSEcCtD
Rasagiline—BCL2—Validated targets of C-MYC transcriptional repression—MYC—brain cancer	0.000704	0.00383	CbGpPWpGaD
Rasagiline—Eye disorder—Temozolomide—brain cancer	0.000703	0.0014	CcSEcCtD
Rasagiline—Urticaria—Procarbazine—brain cancer	0.000702	0.00139	CcSEcCtD
Rasagiline—Body temperature increased—Procarbazine—brain cancer	0.000698	0.00139	CcSEcCtD
Rasagiline—Abdominal pain—Procarbazine—brain cancer	0.000698	0.00139	CcSEcCtD
Rasagiline—Cardiac disorder—Temozolomide—brain cancer	0.000698	0.00139	CcSEcCtD
Rasagiline—BCL2—C-MYB transcription factor network—CCND1—brain cancer	0.000698	0.00379	CbGpPWpGaD
Rasagiline—BCL2—Senescence and Autophagy in Cancer—CDKN2A—brain cancer	0.000691	0.00375	CbGpPWpGaD
Rasagiline—Alopecia—Carmustine—brain cancer	0.000687	0.00137	CcSEcCtD
Rasagiline—BCL2—Focal Adhesion—PDGFRA—brain cancer	0.000683	0.00371	CbGpPWpGaD
Rasagiline—Angiopathy—Temozolomide—brain cancer	0.000682	0.00135	CcSEcCtD
Rasagiline—Mental disorder—Carmustine—brain cancer	0.000682	0.00135	CcSEcCtD
Rasagiline—BCL2—Integrated Pancreatic Cancer Pathway—PDGFRA—brain cancer	0.00068	0.00369	CbGpPWpGaD
Rasagiline—Infection—Hydroxyurea—brain cancer	0.000679	0.00135	CcSEcCtD
Rasagiline—Immune system disorder—Temozolomide—brain cancer	0.000679	0.00135	CcSEcCtD
Rasagiline—Mediastinal disorder—Temozolomide—brain cancer	0.000678	0.00135	CcSEcCtD
Rasagiline—Malnutrition—Carmustine—brain cancer	0.000677	0.00134	CcSEcCtD
Rasagiline—BCL2—Direct p53 effectors—APC—brain cancer	0.000676	0.00367	CbGpPWpGaD
Rasagiline—BCL2—Integrated Breast Cancer Pathway—CDK4—brain cancer	0.000676	0.00367	CbGpPWpGaD
Rasagiline—Chills—Temozolomide—brain cancer	0.000675	0.00134	CcSEcCtD
Rasagiline—Nervous system disorder—Hydroxyurea—brain cancer	0.00067	0.00133	CcSEcCtD
Rasagiline—BCL2—DNA Damage Response (only ATM dependent)—CDKN2A—brain cancer	0.00067	0.00364	CbGpPWpGaD
Rasagiline—Infestation—Etoposide—brain cancer	0.00067	0.00133	CcSEcCtD
Rasagiline—Infestation NOS—Etoposide—brain cancer	0.00067	0.00133	CcSEcCtD
Rasagiline—BCL2—Corticotropin-releasing hormone—IL2—brain cancer	0.000665	0.00362	CbGpPWpGaD
Rasagiline—Alopecia—Temozolomide—brain cancer	0.000664	0.00132	CcSEcCtD
Rasagiline—Skin disorder—Hydroxyurea—brain cancer	0.000664	0.00132	CcSEcCtD
Rasagiline—BCL2—Focal Adhesion—SPP1—brain cancer	0.000663	0.0036	CbGpPWpGaD
Rasagiline—Acute coronary syndrome—Etoposide—brain cancer	0.000661	0.00131	CcSEcCtD
Rasagiline—Mental disorder—Temozolomide—brain cancer	0.000659	0.00131	CcSEcCtD
Rasagiline—Neuropathy peripheral—Etoposide—brain cancer	0.000657	0.0013	CcSEcCtD
Rasagiline—Myocardial infarction—Etoposide—brain cancer	0.000657	0.0013	CcSEcCtD
Rasagiline—Back pain—Carmustine—brain cancer	0.000655	0.0013	CcSEcCtD
Rasagiline—Malnutrition—Temozolomide—brain cancer	0.000654	0.0013	CcSEcCtD
Rasagiline—Jaundice—Etoposide—brain cancer	0.000653	0.0013	CcSEcCtD
Rasagiline—Stomatitis—Etoposide—brain cancer	0.000653	0.0013	CcSEcCtD
Rasagiline—Anorexia—Hydroxyurea—brain cancer	0.000652	0.00129	CcSEcCtD
Rasagiline—Hypersensitivity—Procarbazine—brain cancer	0.000651	0.00129	CcSEcCtD
Rasagiline—BCL2—Integrated Pancreatic Cancer Pathway—PCNA—brain cancer	0.000648	0.00352	CbGpPWpGaD
Rasagiline—BCL2—Corticotropin-releasing hormone—CTNNB1—brain cancer	0.000642	0.00349	CbGpPWpGaD
Rasagiline—BCL2—DNA Damage Response (only ATM dependent)—ERBB2—brain cancer	0.000641	0.00348	CbGpPWpGaD
Rasagiline—Dysgeusia—Temozolomide—brain cancer	0.000641	0.00127	CcSEcCtD
Rasagiline—CYP1A2—Estrogen Receptor Pathway—STAT3—brain cancer	0.000638	0.00347	CbGpPWpGaD
Rasagiline—Tremor—Carmustine—brain cancer	0.000634	0.00126	CcSEcCtD
Rasagiline—Asthenia—Procarbazine—brain cancer	0.000634	0.00126	CcSEcCtD
Rasagiline—Back pain—Temozolomide—brain cancer	0.000633	0.00126	CcSEcCtD
Rasagiline—Anaemia—Carmustine—brain cancer	0.000626	0.00124	CcSEcCtD
Rasagiline—Pruritus—Procarbazine—brain cancer	0.000625	0.00124	CcSEcCtD
Rasagiline—BCL2—Apoptosis—APC—brain cancer	0.000623	0.00339	CbGpPWpGaD
Rasagiline—Agitation—Carmustine—brain cancer	0.000622	0.00124	CcSEcCtD
Rasagiline—Tremor—Temozolomide—brain cancer	0.000613	0.00122	CcSEcCtD
Rasagiline—Dyspnoea—Hydroxyurea—brain cancer	0.00061	0.00121	CcSEcCtD
Rasagiline—Somnolence—Hydroxyurea—brain cancer	0.000608	0.00121	CcSEcCtD
Rasagiline—Ill-defined disorder—Temozolomide—brain cancer	0.000607	0.00121	CcSEcCtD
Rasagiline—Leukopenia—Carmustine—brain cancer	0.000606	0.0012	CcSEcCtD
Rasagiline—Anaemia—Temozolomide—brain cancer	0.000605	0.0012	CcSEcCtD
Rasagiline—Diarrhoea—Procarbazine—brain cancer	0.000604	0.0012	CcSEcCtD
Rasagiline—Dyspepsia—Hydroxyurea—brain cancer	0.000602	0.0012	CcSEcCtD
Rasagiline—Agitation—Temozolomide—brain cancer	0.000601	0.00119	CcSEcCtD
Rasagiline—Hypoaesthesia—Etoposide—brain cancer	0.000599	0.00119	CcSEcCtD
Rasagiline—Decreased appetite—Hydroxyurea—brain cancer	0.000594	0.00118	CcSEcCtD
Rasagiline—Urinary tract disorder—Etoposide—brain cancer	0.000594	0.00118	CcSEcCtD
Rasagiline—Gastrointestinal disorder—Hydroxyurea—brain cancer	0.00059	0.00117	CcSEcCtD
Rasagiline—Malaise—Temozolomide—brain cancer	0.00059	0.00117	CcSEcCtD
Rasagiline—Urethral disorder—Etoposide—brain cancer	0.00059	0.00117	CcSEcCtD
Rasagiline—Vertigo—Temozolomide—brain cancer	0.000588	0.00117	CcSEcCtD
Rasagiline—Convulsion—Carmustine—brain cancer	0.000587	0.00117	CcSEcCtD
Rasagiline—Leukopenia—Temozolomide—brain cancer	0.000586	0.00116	CcSEcCtD
Rasagiline—Hypertension—Carmustine—brain cancer	0.000585	0.00116	CcSEcCtD
Rasagiline—Constipation—Hydroxyurea—brain cancer	0.000585	0.00116	CcSEcCtD
Rasagiline—Dizziness—Procarbazine—brain cancer	0.000584	0.00116	CcSEcCtD
Rasagiline—Chest pain—Carmustine—brain cancer	0.000577	0.00114	CcSEcCtD
Rasagiline—Anxiety—Carmustine—brain cancer	0.000575	0.00114	CcSEcCtD
Rasagiline—Cough—Temozolomide—brain cancer	0.000571	0.00113	CcSEcCtD
Rasagiline—Convulsion—Temozolomide—brain cancer	0.000567	0.00113	CcSEcCtD
Rasagiline—BCL2—DNA Damage Response (only ATM dependent)—CCND1—brain cancer	0.000566	0.00308	CbGpPWpGaD
Rasagiline—Hypertension—Temozolomide—brain cancer	0.000565	0.00112	CcSEcCtD
Rasagiline—Feeling abnormal—Hydroxyurea—brain cancer	0.000563	0.00112	CcSEcCtD
Rasagiline—Eye disorder—Etoposide—brain cancer	0.000562	0.00112	CcSEcCtD
Rasagiline—Vomiting—Procarbazine—brain cancer	0.000562	0.00112	CcSEcCtD
Rasagiline—BCL2—DNA Damage Response (only ATM dependent)—CTNNB1—brain cancer	0.000561	0.00305	CbGpPWpGaD
Rasagiline—BCL2—Integrated Pancreatic Cancer Pathway—CDK4—brain cancer	0.00056	0.00304	CbGpPWpGaD
Rasagiline—BCL2—Apoptosis—MYC—brain cancer	0.00056	0.00304	CbGpPWpGaD
Rasagiline—BCL2—C-MYB transcription factor network—MYC—brain cancer	0.00056	0.00304	CbGpPWpGaD
Rasagiline—Cardiac disorder—Etoposide—brain cancer	0.000558	0.00111	CcSEcCtD
Rasagiline—Confusional state—Carmustine—brain cancer	0.000557	0.00111	CcSEcCtD
Rasagiline—Arthralgia—Temozolomide—brain cancer	0.000557	0.00111	CcSEcCtD
Rasagiline—Rash—Procarbazine—brain cancer	0.000557	0.00111	CcSEcCtD
Rasagiline—Dermatitis—Procarbazine—brain cancer	0.000557	0.00111	CcSEcCtD
Rasagiline—Anxiety—Temozolomide—brain cancer	0.000555	0.0011	CcSEcCtD
Rasagiline—Headache—Procarbazine—brain cancer	0.000553	0.0011	CcSEcCtD
Rasagiline—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—brain cancer	0.000553	0.0011	CcSEcCtD
Rasagiline—Discomfort—Temozolomide—brain cancer	0.00055	0.00109	CcSEcCtD
Rasagiline—Infection—Carmustine—brain cancer	0.000549	0.00109	CcSEcCtD
Rasagiline—Angiopathy—Etoposide—brain cancer	0.000546	0.00108	CcSEcCtD
Rasagiline—Dry mouth—Temozolomide—brain cancer	0.000545	0.00108	CcSEcCtD
Rasagiline—Immune system disorder—Etoposide—brain cancer	0.000543	0.00108	CcSEcCtD
Rasagiline—Mediastinal disorder—Etoposide—brain cancer	0.000542	0.00108	CcSEcCtD
Rasagiline—Body temperature increased—Hydroxyurea—brain cancer	0.00054	0.00107	CcSEcCtD
Rasagiline—Chills—Etoposide—brain cancer	0.00054	0.00107	CcSEcCtD
Rasagiline—Confusional state—Temozolomide—brain cancer	0.000539	0.00107	CcSEcCtD
Rasagiline—Alopecia—Etoposide—brain cancer	0.000532	0.00106	CcSEcCtD
Rasagiline—CYP1A2—Aryl Hydrocarbon Receptor Pathway—HES1—brain cancer	0.000531	0.00289	CbGpPWpGaD
Rasagiline—Infection—Temozolomide—brain cancer	0.000531	0.00105	CcSEcCtD
Rasagiline—BCL2—Focal Adhesion—PIK3CG—brain cancer	0.000529	0.00288	CbGpPWpGaD
Rasagiline—BCL2—Integrated Pancreatic Cancer Pathway—APC—brain cancer	0.000527	0.00286	CbGpPWpGaD
Rasagiline—Anorexia—Carmustine—brain cancer	0.000527	0.00105	CcSEcCtD
Rasagiline—Nausea—Procarbazine—brain cancer	0.000525	0.00104	CcSEcCtD
Rasagiline—Nervous system disorder—Temozolomide—brain cancer	0.000524	0.00104	CcSEcCtD
Rasagiline—Skin disorder—Temozolomide—brain cancer	0.000519	0.00103	CcSEcCtD
Rasagiline—Hypotension—Carmustine—brain cancer	0.000516	0.00103	CcSEcCtD
Rasagiline—Hyperhidrosis—Temozolomide—brain cancer	0.000516	0.00103	CcSEcCtD
Rasagiline—CYP1A2—Biological oxidations—CYP2C9—brain cancer	0.000515	0.0028	CbGpPWpGaD
Rasagiline—Dysgeusia—Etoposide—brain cancer	0.000513	0.00102	CcSEcCtD
Rasagiline—Anorexia—Temozolomide—brain cancer	0.000509	0.00101	CcSEcCtD
Rasagiline—CYP1A2—Metapathway biotransformation—CYP2C9—brain cancer	0.000508	0.00276	CbGpPWpGaD
Rasagiline—Back pain—Etoposide—brain cancer	0.000507	0.00101	CcSEcCtD
Rasagiline—Hypersensitivity—Hydroxyurea—brain cancer	0.000504	0.001	CcSEcCtD
Rasagiline—Musculoskeletal discomfort—Carmustine—brain cancer	0.000504	0.001	CcSEcCtD
Rasagiline—Muscle spasms—Etoposide—brain cancer	0.000503	0.001	CcSEcCtD
Rasagiline—Insomnia—Carmustine—brain cancer	0.0005	0.000993	CcSEcCtD
Rasagiline—Paraesthesia—Carmustine—brain cancer	0.000496	0.000986	CcSEcCtD
Rasagiline—Dyspnoea—Carmustine—brain cancer	0.000493	0.000979	CcSEcCtD
Rasagiline—Somnolence—Carmustine—brain cancer	0.000491	0.000976	CcSEcCtD
Rasagiline—Asthenia—Hydroxyurea—brain cancer	0.000491	0.000974	CcSEcCtD
Rasagiline—Musculoskeletal discomfort—Temozolomide—brain cancer	0.000487	0.000966	CcSEcCtD
Rasagiline—Ill-defined disorder—Etoposide—brain cancer	0.000486	0.000965	CcSEcCtD
Rasagiline—Anaemia—Etoposide—brain cancer	0.000484	0.000961	CcSEcCtD
Rasagiline—Insomnia—Temozolomide—brain cancer	0.000483	0.000959	CcSEcCtD
Rasagiline—Decreased appetite—Carmustine—brain cancer	0.00048	0.000954	CcSEcCtD
Rasagiline—Paraesthesia—Temozolomide—brain cancer	0.00048	0.000952	CcSEcCtD
Rasagiline—Gastrointestinal disorder—Carmustine—brain cancer	0.000477	0.000948	CcSEcCtD
Rasagiline—Dyspnoea—Temozolomide—brain cancer	0.000476	0.000946	CcSEcCtD
Rasagiline—Somnolence—Temozolomide—brain cancer	0.000475	0.000943	CcSEcCtD
Rasagiline—Constipation—Carmustine—brain cancer	0.000473	0.000939	CcSEcCtD
Rasagiline—Malaise—Etoposide—brain cancer	0.000472	0.000938	CcSEcCtD
Rasagiline—Vertigo—Etoposide—brain cancer	0.000471	0.000934	CcSEcCtD
Rasagiline—Dyspepsia—Temozolomide—brain cancer	0.00047	0.000934	CcSEcCtD
Rasagiline—Leukopenia—Etoposide—brain cancer	0.000469	0.000931	CcSEcCtD
Rasagiline—Diarrhoea—Hydroxyurea—brain cancer	0.000468	0.000929	CcSEcCtD
Rasagiline—Decreased appetite—Temozolomide—brain cancer	0.000464	0.000922	CcSEcCtD
Rasagiline—Gastrointestinal disorder—Temozolomide—brain cancer	0.000461	0.000916	CcSEcCtD
Rasagiline—Loss of consciousness—Etoposide—brain cancer	0.00046	0.000914	CcSEcCtD
Rasagiline—BCL2—Apoptosis—TP53—brain cancer	0.00046	0.0025	CbGpPWpGaD
Rasagiline—Cough—Etoposide—brain cancer	0.000457	0.000907	CcSEcCtD
Rasagiline—Constipation—Temozolomide—brain cancer	0.000457	0.000907	CcSEcCtD
Rasagiline—Feeling abnormal—Carmustine—brain cancer	0.000455	0.000904	CcSEcCtD
Rasagiline—BCL2—DNA Damage Response (only ATM dependent)—MYC—brain cancer	0.000454	0.00247	CbGpPWpGaD
Rasagiline—Convulsion—Etoposide—brain cancer	0.000454	0.000901	CcSEcCtD
Rasagiline—Hypertension—Etoposide—brain cancer	0.000452	0.000898	CcSEcCtD
Rasagiline—Dizziness—Hydroxyurea—brain cancer	0.000452	0.000898	CcSEcCtD
Rasagiline—Gastrointestinal pain—Carmustine—brain cancer	0.000452	0.000898	CcSEcCtD
Rasagiline—Chest pain—Etoposide—brain cancer	0.000446	0.000885	CcSEcCtD
Rasagiline—Unspecified disorder of skin and subcutaneous tissue—Etoposide—brain cancer	0.000443	0.000879	CcSEcCtD
Rasagiline—Discomfort—Etoposide—brain cancer	0.000441	0.000875	CcSEcCtD
Rasagiline—Feeling abnormal—Temozolomide—brain cancer	0.00044	0.000874	CcSEcCtD
Rasagiline—Abdominal pain—Carmustine—brain cancer	0.000437	0.000868	CcSEcCtD
Rasagiline—Body temperature increased—Carmustine—brain cancer	0.000437	0.000868	CcSEcCtD
Rasagiline—Gastrointestinal pain—Temozolomide—brain cancer	0.000437	0.000867	CcSEcCtD
Rasagiline—BCL2—Integrated Breast Cancer Pathway—CCND1—brain cancer	0.000436	0.00237	CbGpPWpGaD
Rasagiline—Vomiting—Hydroxyurea—brain cancer	0.000435	0.000863	CcSEcCtD
Rasagiline—BCL2—Integrated Breast Cancer Pathway—CTNNB1—brain cancer	0.000432	0.00235	CbGpPWpGaD
Rasagiline—Rash—Hydroxyurea—brain cancer	0.000431	0.000856	CcSEcCtD
Rasagiline—BCL2—Apoptosis Modulation and Signaling—TP53—brain cancer	0.000431	0.00234	CbGpPWpGaD
Rasagiline—Confusional state—Etoposide—brain cancer	0.000431	0.000856	CcSEcCtD
Rasagiline—Dermatitis—Hydroxyurea—brain cancer	0.000431	0.000855	CcSEcCtD
Rasagiline—Headache—Hydroxyurea—brain cancer	0.000428	0.000851	CcSEcCtD
Rasagiline—Infection—Etoposide—brain cancer	0.000425	0.000843	CcSEcCtD
Rasagiline—Urticaria—Temozolomide—brain cancer	0.000424	0.000843	CcSEcCtD
Rasagiline—BCL2—Apoptosis—CTNNB1—brain cancer	0.000423	0.0023	CbGpPWpGaD
Rasagiline—Abdominal pain—Temozolomide—brain cancer	0.000422	0.000838	CcSEcCtD
Rasagiline—Body temperature increased—Temozolomide—brain cancer	0.000422	0.000838	CcSEcCtD
Rasagiline—Skin disorder—Etoposide—brain cancer	0.000415	0.000824	CcSEcCtD
Rasagiline—Hyperhidrosis—Etoposide—brain cancer	0.000413	0.000821	CcSEcCtD
Rasagiline—BCL2—Focal Adhesion—ERBB2—brain cancer	0.000411	0.00223	CbGpPWpGaD
Rasagiline—BCL2—Integrated Pancreatic Cancer Pathway—ERBB2—brain cancer	0.000409	0.00222	CbGpPWpGaD
Rasagiline—Anorexia—Etoposide—brain cancer	0.000407	0.000809	CcSEcCtD
Rasagiline—Hypersensitivity—Carmustine—brain cancer	0.000407	0.000809	CcSEcCtD
Rasagiline—Nausea—Hydroxyurea—brain cancer	0.000406	0.000806	CcSEcCtD
Rasagiline—Hypotension—Etoposide—brain cancer	0.000399	0.000793	CcSEcCtD
Rasagiline—Asthenia—Carmustine—brain cancer	0.000397	0.000787	CcSEcCtD
Rasagiline—Hypersensitivity—Temozolomide—brain cancer	0.000394	0.000781	CcSEcCtD
Rasagiline—BCL2—Senescence and Autophagy in Cancer—TP53—brain cancer	0.000384	0.00209	CbGpPWpGaD
Rasagiline—Paraesthesia—Etoposide—brain cancer	0.000384	0.000762	CcSEcCtD
Rasagiline—Asthenia—Temozolomide—brain cancer	0.000383	0.000761	CcSEcCtD
Rasagiline—Dyspnoea—Etoposide—brain cancer	0.000381	0.000757	CcSEcCtD
Rasagiline—MAOB—Metabolism—CYP2C9—brain cancer	0.000381	0.00207	CbGpPWpGaD
Rasagiline—BCL2—Integrated Breast Cancer Pathway—VEGFA—brain cancer	0.00038	0.00207	CbGpPWpGaD
Rasagiline—Somnolence—Etoposide—brain cancer	0.00038	0.000755	CcSEcCtD
Rasagiline—Diarrhoea—Carmustine—brain cancer	0.000378	0.000751	CcSEcCtD
Rasagiline—Pruritus—Temozolomide—brain cancer	0.000378	0.00075	CcSEcCtD
Rasagiline—BCL2—DNA Damage Response (only ATM dependent)—TP53—brain cancer	0.000373	0.00203	CbGpPWpGaD
Rasagiline—Decreased appetite—Etoposide—brain cancer	0.000372	0.000738	CcSEcCtD
Rasagiline—Gastrointestinal disorder—Etoposide—brain cancer	0.000369	0.000733	CcSEcCtD
Rasagiline—Dizziness—Carmustine—brain cancer	0.000365	0.000726	CcSEcCtD
Rasagiline—Constipation—Etoposide—brain cancer	0.000365	0.000726	CcSEcCtD
Rasagiline—Diarrhoea—Temozolomide—brain cancer	0.000365	0.000726	CcSEcCtD
Rasagiline—BCL2—Direct p53 effectors—EGFR—brain cancer	0.000364	0.00198	CbGpPWpGaD
Rasagiline—BCL2—Focal Adhesion—CCND1—brain cancer	0.000363	0.00197	CbGpPWpGaD
Rasagiline—BCL2—Integrated Pancreatic Cancer Pathway—CCND1—brain cancer	0.000362	0.00196	CbGpPWpGaD
Rasagiline—BCL2—Focal Adhesion—CTNNB1—brain cancer	0.00036	0.00195	CbGpPWpGaD
Rasagiline—BCL2—Integrated Pancreatic Cancer Pathway—CTNNB1—brain cancer	0.000358	0.00195	CbGpPWpGaD
Rasagiline—Dizziness—Temozolomide—brain cancer	0.000353	0.000701	CcSEcCtD
Rasagiline—Feeling abnormal—Etoposide—brain cancer	0.000352	0.000699	CcSEcCtD
Rasagiline—Vomiting—Carmustine—brain cancer	0.000351	0.000698	CcSEcCtD
Rasagiline—BCL2—Integrated Breast Cancer Pathway—MYC—brain cancer	0.00035	0.0019	CbGpPWpGaD
Rasagiline—Gastrointestinal pain—Etoposide—brain cancer	0.000349	0.000694	CcSEcCtD
Rasagiline—Rash—Carmustine—brain cancer	0.000348	0.000692	CcSEcCtD
Rasagiline—Dermatitis—Carmustine—brain cancer	0.000348	0.000691	CcSEcCtD
Rasagiline—Headache—Carmustine—brain cancer	0.000346	0.000688	CcSEcCtD
Rasagiline—BCL2—Innate Immune System—VAV1—brain cancer	0.000343	0.00186	CbGpPWpGaD
Rasagiline—BCL2—Integrated Breast Cancer Pathway—EGFR—brain cancer	0.000342	0.00186	CbGpPWpGaD
Rasagiline—Vomiting—Temozolomide—brain cancer	0.00034	0.000674	CcSEcCtD
Rasagiline—Urticaria—Etoposide—brain cancer	0.00034	0.000674	CcSEcCtD
Rasagiline—Abdominal pain—Etoposide—brain cancer	0.000338	0.000671	CcSEcCtD
Rasagiline—Body temperature increased—Etoposide—brain cancer	0.000338	0.000671	CcSEcCtD
Rasagiline—Rash—Temozolomide—brain cancer	0.000337	0.000669	CcSEcCtD
Rasagiline—Dermatitis—Temozolomide—brain cancer	0.000336	0.000668	CcSEcCtD
Rasagiline—Headache—Temozolomide—brain cancer	0.000335	0.000664	CcSEcCtD
Rasagiline—Nausea—Carmustine—brain cancer	0.000328	0.000652	CcSEcCtD
Rasagiline—MAOB—Metabolism—BSG—brain cancer	0.000324	0.00176	CbGpPWpGaD
Rasagiline—Nausea—Temozolomide—brain cancer	0.000317	0.00063	CcSEcCtD
Rasagiline—BCL2—Focal Adhesion—VEGFA—brain cancer	0.000317	0.00172	CbGpPWpGaD
Rasagiline—BCL2—Integrated Pancreatic Cancer Pathway—VEGFA—brain cancer	0.000315	0.00171	CbGpPWpGaD
Rasagiline—Hypersensitivity—Etoposide—brain cancer	0.000315	0.000625	CcSEcCtD
Rasagiline—Asthenia—Etoposide—brain cancer	0.000307	0.000609	CcSEcCtD
Rasagiline—CYP1A2—Aryl Hydrocarbon Receptor—RELA—brain cancer	0.000306	0.00167	CbGpPWpGaD
Rasagiline—BCL2—Direct p53 effectors—TP53—brain cancer	0.000305	0.00166	CbGpPWpGaD
Rasagiline—Pruritus—Etoposide—brain cancer	0.000302	0.0006	CcSEcCtD
Rasagiline—Diarrhoea—Etoposide—brain cancer	0.000292	0.000581	CcSEcCtD
Rasagiline—BCL2—Integrated Pancreatic Cancer Pathway—MYC—brain cancer	0.00029	0.00158	CbGpPWpGaD
Rasagiline—BCL2—Integrated Breast Cancer Pathway—TP53—brain cancer	0.000287	0.00156	CbGpPWpGaD
Rasagiline—BCL2—Focal Adhesion—EGFR—brain cancer	0.000285	0.00155	CbGpPWpGaD
Rasagiline—BCL2—Integrated Pancreatic Cancer Pathway—EGFR—brain cancer	0.000284	0.00154	CbGpPWpGaD
Rasagiline—Dizziness—Etoposide—brain cancer	0.000283	0.000561	CcSEcCtD
Rasagiline—BCL2—Apoptosis—TP53—brain cancer	0.000282	0.00153	CbGpPWpGaD
Rasagiline—BCL2—Innate Immune System—PDGFRA—brain cancer	0.000281	0.00153	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—IDH1—brain cancer	0.000278	0.00151	CbGpPWpGaD
Rasagiline—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—brain cancer	0.000276	0.0015	CbGpPWpGaD
Rasagiline—Vomiting—Etoposide—brain cancer	0.000272	0.00054	CcSEcCtD
Rasagiline—Rash—Etoposide—brain cancer	0.000269	0.000535	CcSEcCtD
Rasagiline—Dermatitis—Etoposide—brain cancer	0.000269	0.000535	CcSEcCtD
Rasagiline—Headache—Etoposide—brain cancer	0.000268	0.000532	CcSEcCtD
Rasagiline—BCL2—Immune System—SKP2—brain cancer	0.000262	0.00142	CbGpPWpGaD
Rasagiline—Nausea—Etoposide—brain cancer	0.000254	0.000504	CcSEcCtD
Rasagiline—BCL2—Innate Immune System—IRS2—brain cancer	0.000246	0.00134	CbGpPWpGaD
Rasagiline—BCL2—Integrated Pancreatic Cancer Pathway—TP53—brain cancer	0.000238	0.00129	CbGpPWpGaD
Rasagiline—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—brain cancer	0.000235	0.00127	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—ENO2—brain cancer	0.00022	0.0012	CbGpPWpGaD
Rasagiline—CYP1A2—Aryl Hydrocarbon Receptor—MYC—brain cancer	0.000216	0.00117	CbGpPWpGaD
Rasagiline—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—brain cancer	0.000211	0.00115	CbGpPWpGaD
Rasagiline—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—brain cancer	0.000211	0.00115	CbGpPWpGaD
Rasagiline—BCL2—Immune System—VAV1—brain cancer	0.0002	0.00108	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	0.000198	0.00107	CbGpPWpGaD
Rasagiline—BCL2—Innate Immune System—RELA—brain cancer	0.00017	0.000924	CbGpPWpGaD
Rasagiline—BCL2—Innate Immune System—ERBB2—brain cancer	0.000169	0.000918	CbGpPWpGaD
Rasagiline—BCL2—Immune System—PDGFRA—brain cancer	0.000164	0.000888	CbGpPWpGaD
Rasagiline—BCL2—Innate Immune System—CTNNB1—brain cancer	0.000148	0.000804	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism of lipids and lipoproteins—IDH1—brain cancer	0.000145	0.000786	CbGpPWpGaD
Rasagiline—BCL2—Immune System—IRS2—brain cancer	0.000144	0.00078	CbGpPWpGaD
Rasagiline—BCL2—Innate Immune System—EGFR—brain cancer	0.000117	0.000637	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—PIK3CG—brain cancer	0.000101	0.000548	CbGpPWpGaD
Rasagiline—BCL2—Immune System—RELA—brain cancer	9.91e-05	0.000538	CbGpPWpGaD
Rasagiline—BCL2—Immune System—ERBB2—brain cancer	9.84e-05	0.000535	CbGpPWpGaD
Rasagiline—BCL2—Immune System—IL2—brain cancer	8.92e-05	0.000485	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—CYP2C9—brain cancer	8.81e-05	0.000479	CbGpPWpGaD
Rasagiline—BCL2—Immune System—CTNNB1—brain cancer	8.61e-05	0.000468	CbGpPWpGaD
Rasagiline—BCL2—Immune System—STAT3—brain cancer	7.51e-05	0.000408	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—BSG—brain cancer	7.49e-05	0.000407	CbGpPWpGaD
Rasagiline—BCL2—Immune System—EGFR—brain cancer	6.82e-05	0.000371	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—IDH1—brain cancer	6.44e-05	0.00035	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	5.24e-05	0.000285	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—ENO2—brain cancer	5.09e-05	0.000277	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—PIK3CG—brain cancer	2.34e-05	0.000127	CbGpPWpGaD
